Involvement of endoplasmic reticulum stress in rifampicin-induced liver injury.

Front Pharmacol

Department of Hepatobiliary Surgery, Anhui Province Key Laboratory of Hepatopancreatobiliary Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.

Published: October 2022

Rifampicin is a first-line antituberculosis drug. Hepatocyte toxicity caused by rifampicin is a significant clinical problem. However, the specific mechanism by which rifampicin causes liver injury is still poorly understood. Endoplasmic reticulum (ER) stress can have both protective and proapoptotic effects on an organism, depending on the environmental state of the organism. While causing cholestasis and oxidative stress in the liver, rifampicin also activates ER stress in different ways, including bile acid accumulation and cytochrome p450 (CYP) enzyme-induced toxic drug metabolites pregnane X receptor (PXR). The short-term stress response helps the organism resist toxicity, but when persisting, the response aggravates liver damage. Therefore, ER stress may be closely related to the "adaptive" mechanism and the apoptotic toxicity of rifampicin. This article reviews the functional characteristics of ER stress and its potentially pathogenic role in liver injury caused by rifampicin.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630567PMC
http://dx.doi.org/10.3389/fphar.2022.1022809DOI Listing

Publication Analysis

Top Keywords

liver injury
12
endoplasmic reticulum
8
reticulum stress
8
caused rifampicin
8
stress
7
rifampicin
6
liver
5
involvement endoplasmic
4
stress rifampicin-induced
4
rifampicin-induced liver
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!